Aberrant expression of lysophosphatidic acid (LPA) receptors in human colorectal cancer (Q40541052)

21 September 2017

title

Aberrant expression of lysophosphatidic acid (LPA) receptors in human colorectal cancer (English)

1 reference

21 September 2017

1 reference

3

1 reference

21 September 2017

13

Hirokazu Nagawa

1 reference

21 September 2017

Dai Shida

1

1 reference

21 September 2017

Toshiaki Watanabe

2

1 reference

21 September 2017

Kotaro Hama

4

1 reference

21 September 2017

Joji Kitayama

5

1 reference

21 September 2017

Hirofumi Sonoda

6

1 reference

21 September 2017

Yasuhiro Kishi

7

1 reference

21 September 2017

Hironori Yamaguchi

8

1 reference

21 September 2017

Shin Sasaki

9

1 reference

21 September 2017

Akihiro Sako

10

1 reference

21 September 2017

Tsuyoshi Konishi

11

1 reference

21 September 2017

Hiroyuki Arai

12

1 reference

21 September 2017

publication date

1 October 2004

1 reference

21 September 2017

published in

Laboratory Investigation

1 reference

21 September 2017

volume

84

1 reference

21 September 2017

issue

10

1 reference

21 September 2017

page(s)

1352-1362

1 reference

Lysophosphatidic acid, a multifunctional phospholipid messenger

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700146

Bioactive lysophospholipids and their G protein-coupled receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700146

The emerging role of lysophosphatidic acid in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700146

Lysophosphatidic acid and ovarian cancer: a paradigm for tumorogenesis and patient management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700146

Plasma lysophosphatidic acid concentration and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700146

Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700146

Lysophospholipids increase interleukin-8 expression in ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700146

Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700146

Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700146

Requirement for the lpA1 lysophosphatidic acid receptor gene in normal suckling behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700146

Characterization of lpa(2) (Edg4) and lpa(1)/lpa(2) (Edg2/Edg4) lysophosphatidic acid receptor knockout mice: signaling deficits without obvious phenotypic abnormality attributable to lpa(2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700146

Lysophosphatidic acid, a novel lipid growth factor for human thyroid cells: over-expression of the high-affinity receptor edg4 in differentiated thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700146

Lysophosphatidic acid is a bioactive mediator in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700146

Expression of lysophosphatidic acid receptors and vascular endothelial growth factor mediating lysophosphatidic acid in the development of human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700146

Serum lysophosphatidic acid is produced through diverse phospholipase pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700146

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700146

Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700146

EGFR signal transactivation in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700146

Lysophosphatidic acid-regulated mitogenic ERK signaling in androgen-insensitive prostate cancer PC-3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700146

Lysophospholipid mediators of immunity and neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700146

Lysophosphatidic acid: receptors, signaling and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700146

Lysophosphatidic acid protects and rescues intestinal epithelial cells from radiation- and chemotherapy-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700146

Cutting edge: differential constitutive expression of functional receptors for lysophosphatidic acid by human blood lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700146

Lysophosphatidic acid receptor-selective effects on Jurkat T cell migration through a Matrigel model basement membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700146

Genetic alterations during colorectal-tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700146

Emerging pathways in colorectal-cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700146

APC mutations are sufficient for the growth of early colorectal adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700146

A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700146

The Min (multiple intestinal neoplasia) mutation: its effect on gut epithelial cell differentiation and interaction with a modifier system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700146

Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700146

Phenotypic variability of familial adenomatous polyposis in 11 unrelated families with identical APC gene mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700146

The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700146

Lipid metabolism and APC: implications for colorectal cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700146

Nonsteroidal anti-inflammatory drugs, eicosanoids, and colorectal cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700146

Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700146

Lysophospholipids--receptor revelations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700146

Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1-phosphate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700146

7 January 2021

Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700146

7 January 2021

Lysophospholipid growth factors in the initiation, progression, metastases, and management of ovarian cancer.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700146

7 January 2021

EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700146

7 January 2021

10.1038/LABINVEST.3700146

Identifiers

DOI

1 reference

21 September 2017

1 reference